Strategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
4
Meta Platforms
META
5
Salesforce
CRM
US Stock MarketDetailed Quotes
IFRX InflaRx
- 1.450
- +0.230+18.85%
Close Apr 29 16:00 ET
98.23MMarket Cap-1.63P/E (TTM)
1.535High1.290Low581.82KVolume1.360Open1.220Pre Close835.64KTurnover1.01%Turnover RatioLossP/E (Static)67.75MShares2.81552wk High1.41P/B83.65MFloat Cap0.82452wk Low--Dividend TTM57.69MShs Float53.100Historical High--Div YieldTTM20.08%Amplitude0.776Historical Low1.436Avg Price1Lot Size
About InflaRx Company
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Company Profile
SymbolIFRX
Company NameInflaRx
Listing DateNov 8, 2017
Issue Price15.00
Founded2007
CEOProfessor Niels Riedemann
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
AddressWinzerlaer Strasse 2
CityJena
ProvinceThueringen
CountryGermany
Zip Code07745
Phone49-36-41-508180
Websitehttp://www.inflarx.de
Company Executives
- Name
- Position
- Salary
- Professor Niels Riedemann
- Executive Director and Chief Executive Officer
- --
- Professor Dr. Renfeng Guo, M.D.
- Executive Director and Chief Scientific Officer
- --
- Dr. Thomas Taapken
- Chief Financial Officer
- --
- Dr. Camilla Chong
- Chief Medical Officer
- --
- Derval O’Carroll
- Senior Vice President and Global Head, Regulatory Affairs and Compliance
- --
- Nicolas Fulpius
- Non-Executive Chairman of the Board
- --
- Hege Hellstrom
- Director
- --
- Richard H. Brudnick
- Independent Director
- --
- Mark Kubler
- Independent Director
- --
- Anthony Gibney
- Independent Director
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call